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ABSTRACT
Cornelia de Lange Syndrome (CdLS) is a rare con-
genital malformation disorder. About half of the
patients with CdLS carry mutations in the NIPBL
gene encoding the NIPBL protein, a subunit of the
Cohesin loading complex. Recent studies show
association of Cohesin with chromatin-remodeling
complexes, either by establishing cohesion or by
recruiting Cohesin to specific chromosome loca-
tions. In yeast two-hybrid assays, we identified an
interaction of NIPBL with the histone deacetylases -1
and -3. These interactions were confirmed in mam-
malian cells by coimmunoprecipitation and a critical
region for interaction was defined to a stretch of 163
amino acids of a highly conserved region of NIPBL,
which is mutated in patients with CdLS. Utilizing
reporter gene assays, we could show that NIPBL
fused to the GAL4-DNA-binding domain (GAL4-
DBD) represses promoter activity via the recruit-
ment of histone deacetylases. Interestingly, this
effect is dramatically reduced by both NIPBL mis-
sense mutations identified in CdLS and by chemical
inhibition of the histone deacetylases. Our data are
the first to indicate a molecular and functional con-
nection of NIPBL with chromatin-remodeling pro-
cesses via the direct interaction with histone
deacetylases.
INTRODUCTION
Following replication, sister chromatids are attached to
each other prior to segregation in mitosis and meiosis.
This association, called sister chromatid cohesion (SCC),
depends on Cohesin, a highly conserved complex of pro-
teins. This complex consists of at least four subunits, the
structural maintenance of chromosomes (SMC) proteins
SMC1 and SMC3, a member of the kleisin protein family
RAD21 and SCC3 (1). Cohesins are thought to form a
ring structure that surrounds the replicated sister chroma-
tids, with SMC1 and SMC3 creating a V-shaped hetero-
dimer, bridged by RAD21 (2,3). SCC3 binds to this
complex via a C-terminal domain of RAD21. The associa-
tion of Cohesin complexes with chromatin appears to be
facilitated by two additional proteins, SCC2 and SCC4.
Recently, a growing number of Cohesins and its regu-
latory proteins have been associated with human develop-
mental disorders. Mutations in ESCO2, which encodes a
factor essential for the establishment of SCC, result in
Roberts syndrome and SC phocomelia (4). In addition,
about 50% of patients with Cornelia de Lange syndrome
(CdLS) have mutations in the NIPBL gene, the human
homolog of the Drosophila Nipped-B and yeast Scc2
gene (5,6). Recently, the ﬁrst missense mutations in
SMC1A and SMC3 were identiﬁed in patients with mild
variants of CdLS (7,8).
Although Cohesins were initially identiﬁed for their role
in SCC, Drosphila Nipped-B was isolated as a protein that
facilitates transcriptional regulation by remote enhancer
sequences (9). Whether SCC2-like proteins have indepen-
dent functions in cohesion and transcription, or whether
these functions are interconnected remains unclear.
Furthermore, increasing evidence indicates that SCC
correlates with chromatin remodeling. The Cohesin’s
SMC1, SMC3 and Scc1/RAD21 have been found to
copurify with a chromatin-remodeling complex contain-
ing the ATPase SNF2h, presumably due to a direct inter-
action between Cohesins and chromatin-remodeling
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tions of the chromatin-remodeling factors RSC and
INO80 that result in defects in SCC (11–13).
To understand the molecular mechanisms underlying
CdLS, we used a yeast two-hybrid screen to identify bind-
ing proteins of NIPBL. We identiﬁed a speciﬁc interaction
of NIPBL with the histone deacetylases-1 and -3 (HDAC1
and HDAC3) that was veriﬁed by coimmunoprecipitation
in eukaryotic cells. Luciferase reporter gene assays and
chromatin-immunoprecipitation analyses support the
model that NIPBL may initiate chromatin-remodeling
processes through the recruitment of these HDACs.
Furthermore, we could show that missense mutations
identiﬁed in patients with CdLS inﬂuence the interaction
of NIPBL with histone deacetylases and result in a
decreased activity of this functional interaction.
MATERIAL AND METHODS
Yeast two-hybrid assay
Two overlapping fragments (fragment N, aa 1117–1899
and fragment C, aa 1838–2597) representing the highly
conserved region of NIPBL were used as yeast two-
hybrid baits. These fragments were PCR-ampliﬁed (pri-
mers available upon request) from a marathon-ready
human fetal brain cDNA library (Clontech-Takara,
Saint-Germain-en-Laye, France). Fragments were inserted
into the Matchmaker GAL4 Two-Hybrid Sytem 3
(Clontech-Takara) pGBKT7 plasmid. Yeast cells were
transformed according to the Matchmaker 3 manual and
bait expression was conﬁrmed by western blotting using
an anti-GAL4-DBD antibody (Santa Cruz, CA, USA).
Human chondrocyte and human ovary cDNA prey
libraries were screened according to the manufacturer’s
protocol (Matchmaker 3, Clontech-Takara). Plasmids
from clones obtained under stringent selection were
isolated and sequenced. Identity was determined using
BlastN and BlastP homology searches. All constructs
used were veriﬁed by sequencing (PE Applied Biosystems,
Darmstadt, Germany).
b-Galactosidase assay
Liquid b-galactosidase assays were performed as per the
manufacturer (Matchmaker 3, Clontech). Brieﬂy, NIPBL-
subfragments 4–8 were generated from fragment C and
inserted into the pGBKT7 plasmid. Full-length HDAC1,
HDAC3 and HDAC6 were ampliﬁed from human fetal
brain cDNA (HDAC1) or full-length ORFs containing
plasmids (InvivoGen, San Diego, USA), restriction sites
added by PCR and inserted into the pGADT7 plasmid
(Clontech-Takara). Yeast cells (AH109) were cotrans-
formed with the NIPBL-fragments 4–8 and all HDAC
containing plasmids, respectively. Proper expression was
veriﬁed by western blotting using speciﬁc anti-GAL4-
DBD and anti-GAL4-AD antibodies (Santa Cruz). The
overnight cultures were measured at 600nm, cells were
harvested and resuspended in buﬀer Z (60mM,
Na2HPO4, 40mM NaH2PO4, 10mM KCl, 1mM
MgSO4, 50mM 2-mercaptoethanol, pH 7.0). An aliquot
(V) was taken and o-nitrophenyl-b-D-galactopyranoside
was added. After a deﬁned incubation period (t) reaction
was stopped by the addition of 1M Na2CO3. The solu-
tions were cleared of insoluble material by centrifugation
and the OD was measured at 420nm. The b-galactosidase
activity (U) was calculated by the following equation:
U=1000 OD400/(t V OD600). All b-galactosidase
activities (U) listed represent the result of at least six inde-
pendent yeast transformants.
Immunoprecipitations
A volume containing 1mg of total protein extracts from
HeLa cells was dissolved in 1ml of incubation buﬀer
(20 mM HEPES pH 7.9, 75mM KCl, 2.5mM MgCl2,
1mM DTT, 0.1% NP-40, 0.5mM phenylmethylsulfonyl
ﬂuoride, 1mM Na3VO4) and Proteinase Inhibitor
Cocktail (Roche). The solutions were precleared with
30ml of preequilibrated Protein G PLUS/Protein A-Agar
Suspension (Calbiochem, Darmstadt, Germany) for
60min. The supernatant was then incubated with 10ml
of anti-delangin (anti-NIPBL) antibody (Absea, Beijing,
China) for 100min and 60ml of preequilibrated A/G-sus-
pension slurry for 12–16h. The loaded suspensions were
precipitated, washed three to ﬁve times with incubation
buﬀer and resuspended in SDS-gel loading buﬀer
[62mM Tris pH 6.8, 2% (w/v) SDS, 10% (v/v) glycerol,
5% (v/v) 2-mercaptoethanol, 0.005% (w/v) bromophenol
blue]. All incubations were carried out at 48C with con-
stant motion using an end-over-end rotor. Precipitates
were analyzed by SDS–PAGE and western blotting
using the anti-delangin (Absea), anti-HDAC1 (Santa
Cruz) and anti-HDAC3 antibodies (Santa Cruz).
Reporter geneassays
NIPBL fragment 4 was inserted into a pcDNA-GAL4-
DBD expression plasmid to obtain the GAL4-NIPBL
fusion construct. Full-length HDAC1 was ampliﬁed and
inserted into pcDNA3.1. HDAC3 and HDAC6 expression
plasmids were obtained from InvivoGen. The GAL4-
TATA-Luc and the GAL4-tk-Luc reporters have been
described (14,15).
Transient transfection assays of COS-7 and CHO cells
were performed in 96 half-area well plates (Corning,
Munich, Germany) with Lipofectamine2000 reagent
(Invitrogen, Karlsruhe, Germany) according to the man-
ufacturer’s instruction. The phRG-TK Renilla luciferase
expression vector (Promega, Mannheim, Germany) was
used as a transfection control. Activity of Fireﬂy and
Renilla luciferase was measured after 48h incubation
with the Dual Luciferase Reporter Assay System
(Promega) in a GeniosPro Luminometer (Tecan,
Crailsheim, Germany). All measurements were performed
in triplicates. Relative luciferase activity was determined
as rate of the average ﬁreﬂy:renilla luciferase activity. To
inhibit histone deacetylases, cells were treated with 100
nM Trichostatin A (Merck) and 5mM Sodium butyrate
(Sigma, Taufkirchen Germany), respectively for 24h
prior to measurement. DMSO was used as negative con-
trol for Trichostatin A treated cells. All assays had a mini-
mum of six replicates.
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As adapted from Wei et al. (18), COS7 cells were
transfected with GAL4-tk-reporter and either the
NIPBL-fragment4 GAL4-DBD or the empty GAL4-
DBD expression plasmids as described. Chromatin immu-
noprecipitation(ChIP)assayswereperformedaccordingto
the manufacturer’s recommendation (Upstate Biotechnol-
ogy, Lake Placid, NY, USA). Proteins were cross-linked to
DNAbyaddingformaldehyde toa1% ﬁnalconcentration.
Chromatin was incubated with anti-acetylated histone 3,
anti-HDAC1 or anti-HDAC3 antibodies (Upstate Bio-
technology; Millipore, Schwalbach, Germany; Santa
Cruz) overnight at 48C. Precipitated immunecomplexes
were treated with proteinase K, and DNA was puriﬁed
by phenol/chloroform extraction for PCR detection with
primers ﬂanking the tk promoter region of the GAL4-
tk-luc reporter (50-agcgtcttgtcattggcg-30 and 50-ttaagcgg
gtcgctgcag-30).Ampliﬁed fragments(102bp)wereanalyzed
on a 1% agarose gel. An SV40 promoter fragment was
ampliﬁed as an internal control (130 bp; 50-ttagtcagcaac
caggtg-30 and 50- gttaggggcgggactatg-30).
RESULTS
Identification of HDAC1and HDAC3 as NIPBLbinding
proteins
The Cohesin complex consists of multiple protein subu-
nits. In order to identify direct binding proteins of NIPBL,
we used the GAL4-Matchmaker III yeast two-hybrid
system (Clontech). In silico analyzes of the NIPBL protein
predict multiple HEAT-repeats, a glutamine-rich region in
the N-terminal part and a bipartite nuclear localization
signal (Figure 1A) (5,6,16). Furthermore, at least two dif-
ferent isoforms of NIPBL exist in humans; a small isoform
[2697 amino acids (aa) and a calculated molecular weight
(mw) of 304 kDa], and a large isoform (2804 aa and mw
316 kDa). Because of the large protein size, we were
unable to express full-length NIPBL in yeast cells and
created two overlapping fragments (fragment N and frag-
ment C). The latter includes the C-terminal half of
NIPBL, which is highly conserved during evolution
(Figure 1A and B). Both fragments were used to screen
human chondrocyte and ovary libraries. Using fragment C
as bait, we isolated more than 250 clones encoding 56
putative NIPBL-binding proteins, which are currently
under investigation. Five of these clones encoded three
overlapping fragments of the histone deacetylases 1
(HDAC1). Three clones coded for the entire open reading
frame of the histone deacetylases 3 (HDAC3), two of
which are independent and only diﬀer in the length of
the 30 untranslated region (UTR) (Table 1).
To conﬁrm our yeast two-hybrid results and to narrow
down the interaction region within NIPBL, we performed
liquid b-galactosidase assays using fragment C and ﬁve
additional constructs (fragments 4–8) encoding overlap-
ping parts of fragment C (Figure 1B). As prey constructs,
we used the full-length open reading frames (ORFs) of
HDAC1 and HDAC3, each fused to the GAL4-activating
domain (GAL4-AD). As shown in Figure 1C, fragments 4
(encoding aa 1838–2000) and 5 (aa 1838–2380) interact
with HDAC1 as well as HDAC3, whereas no interactions
with fragments 6–8 (6: aa 2000–2380; 7: 2000–2598; 8: aa
2200–2597) were detectable. Thus, the HDAC-interacting
region of the NIPBL protein could be narrowed down to
163 aa (1838–2000). This domain includes the highly con-
served HEAT repeats H2 and H3. In addition, we ana-
lyzed the interaction of NIPBL with HDAC6, which was
not identiﬁed in our yeast two-hybrid screens. HDAC6 did
not interact with the NIPBL-fragments.
Missense mutationsaffect theinteraction ofNIPBL
with histonedeacetylases
In separate studies, we identiﬁed a novel de novo missense
NIPBL mutation (R1895T) predicted to result in an
amino acid exchange within the critical region of NIPBL
interaction with HDAC1 and HDAC3. Another missense
mutation (c.5566A>G; p.R1856G) within this region was
recently described by Selicorni et al. (17). Both patients
show classical CdLS facial features and growth but no
limb anomalies. We used site-directed mutagenesis to
create NIPBL-expression plasmids including the amino
acid exchanges R1895T and R1856G, respectively. To
test whether these mutations have any inﬂuence on the
binding capacity of NIPBL to HDAC1 and HDAC3, we
performed b-galactosidase assays. Equal expression levels
of the NIPBL and HDAC fusion proteins were monitored
by western blotting (Figure 1D). While these mutations
do not signiﬁcantly alter the binding of NIPBL to
HDAC1, a 2-fold decrease in b-galactosidase activity sug-
gests a reduction in NIPBL interaction with HDAC3
(Figure 1D).
NIPBL formsstable complexes with endogenousHDAC1
and HDAC3 inmammalian cells
Since the above assays were performed in transformed
yeast cells, we analyzed whether endogenous NIPBL pro-
tein interacts with HDAC-1 and -3 in mammalian cell
lines. Because HeLa cells express detectable amounts of
NIPBL (18), we used a monoclonal anti-NIPBL antibody
to a C-terminal motif of NIPBL (18) for immunoprecipi-
tation. Western blotting of the anti-NIPBL precipitates
with anti-HDAC1 and anti-HDAC3-speciﬁc antibodies
conﬁrms interaction of endogenous NIPBL and HDAC-1
and -3 (Figure 2). No HDAC1- or HDAC3-speciﬁc
signal was detected in control samples using A/G sephar-
ose loaded with anti-Ig antibodies for precipitation.
NIPBL-mediated recruitment ofhistone deacetylases
modifies promoter activity
To further investigate a functional association of NIPBL
with histone deacetylases, we utilized luciferase reporter
gene assays. To accomplish this, the minimal HDAC-
interacting region of NIPBL, fragment 4, was fused to
the GAL4-DBD containing plasmid to obtain a GAL4-
DBD-NIPBL fusion construct. This fusion protein is able
to bind to the promoter regions of reporter plasmids con-
taining GAL4-binding sites 50 to the luciferase cDNA
under the control of the TATA box (TATA-Luc) or the
tk promoter, respectively. Baseline luciferase activities of
6452 Nucleic Acids Research, 2008, Vol. 36, No. 20Figure 1. Predicted structure of the entire NIPBL protein and all fragments used. (A) The two described isoforms (A and B) of NIPBL diﬀer in the
very C-terminal part of the protein only. The domains predicted by in silico analyses are indicated, including the ﬁve HEAT repeats (H1–H5), the
Glutamine (Gln)-rich region (418–462), the bipartite nuclear localization signal [NLS; 1108–1124 and the HP1-interacting motif (22)]. The two
missense mutations R1856G and R1895T are indicated by asterisks. (B) Fragments ‘N’ and ‘C’ were fused to the GAL4-DNA-binding domain and
used as baits in yeast two-hybrid assays. Fragments 4–8 represent overlapping sub-fragments of fragment C and were used in b-galactosidase assays
to narrow down the smallest region necessary for the interaction of NIPBL with HDAC1 and HDAC3. The expression of all constructs was veriﬁed
by the use of an anti-GAL4-DBD antibody. (C) Fragment 4 (columns 1–3) as well as fragment 5 (columns 4–6) interact with HDAC1 (columns 1
and 4) and HDAC3 (columns 2 and 5), whereas no interactions with fragments 6–8 were detectable (data not shown). As additional control,
interaction of HDAC6 with any of the fragments used could be excluded (columns 3 and 6). (D) The two human missense mutations R1856G and
R1895T were generated by site-directed mutagenesis and the binding capacities to HDAC1 and HDAC3 were analyzed and compared to the wild-
type protein, respectively. While both amino acid substitutions do not alter the binding capacities of NIPBL to HDAC1 (compare columns 1 with 2
and 3), the interaction with HDAC3 resulted in a reduction of b-galactosidase activity to 50% for both mutations compared to the wild-type
construct (columns 4–6). Equal expressions of the HDAC1- and HDAC3-GAL4-AD fusion constructs were veriﬁed by western blotting.
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TATA-Luc or the tk promoter plasmids were arbitrarily
set as 100% (Figure 3A, column 1). Notably, cotransfec-
tion with NIPBL results in a concentration-dependent
decrease of reporter activity (Figure 3A, columns 2–4).
To elucidate whether this NIPBL-mediated trans-repres-
sional activity may be due to the recruitment of endogen-
ous histone deacetylases, we cotransfected HDAC1 and
HDAC3 expression plasmids. Both HDACs-1 and -3
result in additional decrease of the promoter activity,
whereas cotransfection with HDAC6 shows no functional
eﬀect (Figure 3B). In control samples, overexpression of
each histone deacetylase (HDAC-1, -3 or -6) in the
absence of the GAL4-DBD-NIPBL construct has no
signiﬁcant inﬂuence on reporter activities (Figure 3B, col-
umns 4, 6 and 8).
To analyze whether the missense mutations R1895T
and R1856G within the HDAC-interacting region of
NIPBL have an eﬀect on NIPBL-mediated repression,
we generated the constructs GAL4-DBD-R1895T and
GAL4-DBD-R1856G. These constructs were used to
transfect diﬀerent cell lines carrying the TATA-Luc
or tK promoter containing reporter plasmid. While
R1895G only slightly decreases NIPBL-mediated repres-
sion (55.4–64.9%), R1856T has a more dramatic eﬀect
(55.5–83.8%; Figure 3C). Equal expression of NIPBL
constructs was veriﬁed by western blotting of extracts
with an anti-GAL4-DBD antibody (Figure 3C).
The activity of NIPBL issensitive to chemical inhibition
of histonedeacetylases
The direct binding of NIPBL with HDAC1 and HDAC3
as shown in our coimmunoprecipitations and the tran-
scriptional repression demonstrated in the luciferase
reporter assays, strongly suggest a functional correlation
of NIPBL and histone deacetylation mechanisms. To
further characterize whether the NIPBL-mediated repres-
sion was dependent upon histone deacetylase activity, we
utilized sodium butyrate (SoBu) and trichostatin A (TSA),
chemical inhibitors of histone deacetylases. Both inhibi-
tors have been shown to result in hyperacetylation of his-
tones H3 and H4, and result in enhanced promoter
activities (19). In their presence, the activity of the
GAL4-DBD-NIPBL fusion construct was nearly abol-
ished (Figure 3D), providing further support between
the function of NIPBL and histone deacetylation.
Notably, TSA- or SoBu-treatment in the presence of the
empty GAL4-DBD construct, demonstrate only a mini-
mal increase in reporter gene activity, suggesting the eﬀect
is directly on the transcriptional repression by NIPBL,
rather than on global up-regulation of transcription.
NIPBL-mediated recruitment ofendogenous HDACs
induces histone deacetylation
To verify that the promoter activity of the GAL4-DBD-
NIPBL fusion is a direct consequence of NIPBL-mediated
recruitment of endogenous HDAC1 and HDAC3, ChIP
assays were conducted. COS7 cells were cotransfected
with tK reporter and the GAL4-DBD-NIPBL construct.
Following formaldehyde cross-linking, anti-HDAC1 and
anti-HDAC3 antibodies were used for immunoprecipita-
tion. Puriﬁed DNA fragments were ampliﬁed by PCR and
analyzed in electrophoresis (Figure 4A). A tK promoter-
speciﬁc fragment of 130 bp was identiﬁed in both anti-
HDAC1 and anti-HDAC3 precipitates, indicating an
interaction of both endogenous histone deacetylases with
the tK promoter (Figure 4A, upper panel, lanes 2 and 4).
In contrast, no signal was detectable in precipitates of
cells transfected with an empty GAL4-DBD plasmid
(Figure 4A, upper panel, lanes 1 and 3). Furthermore,
HDAC1 and HDAC3 do not interact with the SV40 pro-
moter, which regulates the expression of the GAL4-DBD-
NIPBL construct (Figure 4, lower panel). These data
clearly support a role for NIPBL-mediated recruitment
of endogenous histone deacetylases.
Figure 2. NIPBL coimmunoprecipitates with HDAC1 and HDAC3 in
HeLa cells. (A) Expression of NIPBL was detected with an anti-NIPBL
antibody in extracts of HeLa cells (lane 1). The anti-NIPBL antibody
was used for immunoprecipitation of NIPBL from HeLa extracts and
speciﬁc precipitation of NIPBL was monitored (lane 2). (B) HDAC3
was shown with an anti-HDAC3 antibody in HeLa cell extracts (lane
1). The anti-NIPBL antibody and a control anti-IG antibody were used
for immunoprecipitation (IP), respectively. HDAC3 was found to be
coprecipitated with NIPBL (lane 2), whereas no HDAC3-speciﬁc signal
could be detected in the control IP (lane 4). Noncoprecipitated HDAC3
was visible in the supernatant (lane 3). (C) Proper expression of
HDAC1 was monitored in HeLa cell extracts (lane 1). HDAC1 could
only be identiﬁed in the anti-NIPBL precipitates (lane 2), while no
HDAC1-speciﬁc signal was detectable in the IPs using the anti-IG anti-
body (lane 4). Nonprecipitated HDAC1 could be found in the super-
natants of the IPs (lane 3).
Table 1. Clones encoding HDAC1/HDAC3 identiﬁed by yeast two-
hybrid
Clone Protein Insert (position bp) cDNA library
1 HDAC 1 236 –30UTR+26 Chondrocyte
2 HDAC 1 236 30UTR+26 Chondrocyte
3 HDAC 1 3 – 1417 Chondrocyte
4 HDAC 1 53 – 1440 Ovary
5 HDAC 1 53 – 1440 Ovary
6 HDAC 3  4–3 0UTR+13 Chondrocyte
7 HDAC 3  4–3 0UTR+13 Chondrocyte
8 HDAC 3 1 – 30UTR+56 Chondrocyte
The clones encoding HDAC1/HDAC3 are numbered 1–8. The encod-
ing regions of the isolated plasmids are listed by base pair position in
the ORF of HDAC1/HDAC3. The minus ( ) deﬁnes the position in
the 50UTR, 30UTR positions are deﬁned with plus (+).
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chromatin acetylation, we used an assay (20), where chro-
matin is precipitated with an antibody that speciﬁcally
recognizes acetylated lysines-9 and -14 of histone H3.
The precipitated DNA fragments were PCR-ampliﬁed
and analyzed by agarose gel electrophoresis. An expected
130 bp tK promoter-speciﬁc fragment can be ampliﬁed
from control plasmid DNA (Figure 4B, lane 2) and
from chromatin prior to precipitations (Figure 4B, lanes
3 and 4). Interestingly, no PCR product is seen for the
precipitates of cells transfected with the GAL4-DBD-
NIPBL construct, indicating a speciﬁc deacetylation of
the tK promoter (lane 5). However, the tk promoter
PCR product was detectable in controls using the empty
GAL4-DBD plasmid (Figure 4B, lane 6). The acetylation
status of the SV40 promoter that regulates the expression
of the NIPBL construct was monitored in parallel (lower
panel of Figure 4B). As expected, since no GAL4-binding
sites are present in this vector, H3 acetylation is present,
regardless of the presence or absence of the GAL4-DBD-
NIPBL construct (Figure 4B, lanes 5 and 6).
DISCUSSION
NIPBL is a member of the highly conserved Scc2-protein
family. These proteins, required for the loading of Cohesin
onto chromatin, have been implicated in double-strand
DNA repair and in the regulation of gene expression.
Figure 3. NIPBL-mediated recruitment of HDACs induces transcriptional repression. (A) The HDAC-interacting region of NIPBL, fragment 4, was
fused to GAL4-DBD to obtain a GAL4-DBD-NIPBL-frag4 construct (NIPBL-frag4). Cells carrying a luciferase reporter with GAL4-consensus
binding sequences 50 to a LUC reporter gene were transfected with increasing amounts of NIPBL-frag4. The luciferase activity of cells transfected
with an empty GAL4-DBD plasmid was set as 100% (column 1). NIPBL-frag4 reduces the reporter activity in a concentration-dependent manner
(compare columns 1 with 2–4). (B) Cotransfections with HDAC1- as well as HDAC3-encoding plasmids enhance the transcriptional repression
mediated by NIPBL-frag4 (columns 3 and 5), while transfection with HDAC6 does not alter the activity (column 7). As control, the eﬀects of the
individual HDAC on the reporter (HDAC1, 3, 6 and columns 4, 6, 8) were monitored in the absence of NIPBL. (C) Whereas missense mutation
R1895T only slightly decreases the NIPBL-mediated activity (column 3), mutation R1856G severely reduces the activity (column 4). Equal expression
of wild-type and mutant constructs was monitored by the use of an anti-GAL4-DBD antibody in western blots. (D) The eﬀect of TSA and sodium-
butyrate (SoBu) on the trans-repressive activity of the NIPBL-frag4 construct was assessed in COS7 cells. Columns 1–3 show the activities of cells
tansfected with the empty GAL4-DBD plasmid. Here, TSA and SoBu only very slightly increase the activities. Columns 4–6 represent the results of
cells transfected with the NIPBL construct. While the transfection with NIPBL-frag4 decreases reporter gene activity down to 50% in nontreated
cells (column 4), treatments with TSA and SoBu, respectively, almost completely abolish the trans-repressional eﬀect of NIPBL (columns 5 and 6).
Experiments were done at least in triplicates and the standard deviations are indicated by error bars.
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are fairly large, only a few functional domains have been
predicted by in silico analyses. These include a putative
bipartite nuclear localization signal, a glutamine-rich
region, an HP1-interacting motif and several HEAT
repeats, which have been implicated in protein–protein
interactions (21). These HEAT repeats are located
within the C-terminal part of NIPBL, spanning about
amino acids 1300–2500, which is highly conserved in dif-
ferent species and expected to be functionally signiﬁcant.
Moreover, a majority of CdLS-associated missense muta-
tions map to this domain.
In a yeast two-hybrid assay to identﬁy NIPBL-binding
proteins, we isolated the histone deacetylases, HDAC1
and HDAC3, important cofactors that regulate chromatin
structure by deacetylating histone proteins. Through the
use of truncated NIPBL constructs, we reﬁned the critical
region of NIPBL interaction with HDAC1 and HDAC3
to a stretch of 163 aa (1838–2000), which contains two of
the ﬁve conserved HEAT repeats. As the use of partial
fragments of NIPBL could result in altered protein bind-
ing, we analyzed the interaction of full-length NIPBL
with HDAC1 and HDAC3. In immunoprecipitation
assays, we were able to verify the interaction of the endo-
genous NIPBL with both HDAC1 and HDAC3 in
mammalian cells.
To assess relevance of the critical region for the inter-
action of NIPBL with HDAC1 and HDAC3 to CdLS, we
tested two newly identiﬁed NIPBL missense mutations.
One of these we recently identiﬁed as a de novo mutation
(R1895T) and the other was recently described by
Selicorni and colleagues (R1856G). Both patients have
classical CdLS phenotype without limb abnormalities
(17). Each mutation results in decreased binding of
NIPBL to HDAC3, whereas the interaction with
HDAC1 seems to be unaﬀected. Both mutations are
separated by 39 amino acids and are localized within
(R1856G) or adjacent (R1895T) to HEAT-repeat 2.
In luciferase reporter gene assays we show that this
region of NIPBL when fused to the GAL4-DBD modiﬁes
reporter gene expression. Using ChIP assays we show that
this NIPBL-mediated activity is due to direct interaction
with endogenous histone deacetylases. Furthermore,
cotransfection of HDAC1 and HDAC3 result in a further
decrease of promoter activity, whereas HDAC6, which
does not directly associates with the NIPBL fragment,
does not modify the reporter gene expression signiﬁcantly.
Interestingly, the two missense mutations analyzed have
similar eﬀects on HDAC1 and HDAC3 binding aﬃnities,
but exert diﬀerent functional activities. Mutation R1895T
only slightly alters this function, whereas mutant R1856G
signiﬁcantly decreases the activity mediated by NIPBL.
Lastly, chemical inhibition of histone deacetylation by
treatment of the cell cultures with TSA or SoBu almost
completely abolishes the NIPBL-mediated activity. These
data are the ﬁrst to clearly point to a direct functional
connection of the mammalian SCC2-like protein NIPBL
with the recruitment of histone deacetylating enzymes.
Histone acetylation, chromatinremodeling and Cohesin
Although the interplay of chromatin structure and histone
modiﬁcation with Cohesin has been frequently described,
the precise function is poorly understood. It has been
hypothesized that chromatin structure may play an impor-
tant role in determining whether, and where, Cohesin
binds to chromosomes in eukaryotic cells (22).
It is known that histone modiﬁcations aﬀect the recruit-
ment of Cohesin to particular chromosomal loci (23). In
our ChIP analyses, we could show that aa 1838–2000 of
NIPBL are able to initiate the deacetylation of lysine 9 of
histone 3 (H3K9), which would allow its methylation. The
heterochromatin binding protein 1 (HP1), which was also
Figure 4. Chromatin-immunoprecipitation (ChIP) assays. (A) The NIPBL-mediated recruitment of HDAC1 (lane 2) and HDAC3 (lane 4) was shown
by speciﬁc PCR analyses of the puriﬁed anti-HDAC1- and anti-HDAC3-precipitates, whereas no signal was detectable in the precipitates of cells
transfected with the empty GAL4-DBD plasmid (lanes 1 and 3). As control, the association of HDAC1 and HDAC3 with the SV40 promoter was
excluded (lower panel). (B) ChIP assays were used to demonstrate histone deacetylation. The histone deacetylation occurs as the result of the GAL4-
DBD-NIPBL (+) expression (lane 5), but not if the GAL4-DBD is expressed alone ( ) (lane 6). The upper panel of the ﬁgure shows a GAL4-tK
promoter speciﬁc fragment of  130 bp. In the bottom part, a 120 bp PCR product indicating acetylation of the SV40 promoter is shown. Water
(lane 1), plasmid DNA (lane 2) as well as input DNA before immunoprecipitation (lanes 3 and 4) were used as controls. As additional control a
nonspeciﬁc antibody was used for precipitation (a-IG; lanes 7 and 8).
6456 Nucleic Acids Research, 2008, Vol. 36, No. 20described to bind NIPBL (24), recognizes methylated
lysine 9 on histone H3 (H3K9) and deletion of Swi6, the
yeast ortholog of HP1, causes a loss of Cohesin binding
(25). This is consistent with earlier observations that the
interaction between the Scc3 Cohesin subunit with Swi6
is needed to recruit Cohesin to centromeric regions in
yeast (23,26). On the other hand, it was shown very
recently, that the Suv39h-HP1 pathway is not essential
for the enrichment of Cohesin at centromeres in mammals
(27). These observations clearly indicate diﬀerences in the
functional connection of HP1/Swi6 and Cohesins in yeast
and mammalian cells.
In addition to the above literature, it has been shown
that diminishing HDACs by TSA-treatment or mutation
promotes abnormal sister chromatid separation. Sister
chromatids do not separate when cells enter mitosis with
hyperacetylated histones. Thus, the presence of acetylated
histones in mitosis induces both aberrant chromosome
numbers (i.e. aneuploidy) and defects in chromosome
structure (28). Recently, Kimata and colleagues (29)
described TSA-hypersensitivity of a mutant Mis4, a
Cohesin loading adherin protein. TSA-treatment of mis4
mutant cells results in decreasing Cohesin-binding to chro-
matin in the chromosome arm regions. Furthermore, the
correlation of various histone modiﬁcations and Cohesin
is the subject of a continuously growing number of
publications. In human cells, a chromatin-remodeling
complex containing the ATPase SNF2h was found to
copurify with RAD21 and SMC proteins, presumably
due to a direct interaction between Cohesin and this com-
plex (10). Mutations in the yeast chromatin-remodeling
complex RSC cause modest defects in sister-chromatid
cohesion (11,12). Furthermore, deletions of Rsc2, encod-
ing a further alternative variant of the RSC complex,
signiﬁcantly reduces SCC by reducing the amount of
chromosome-associated Cohesins (30).
The function of NIPBL inregulating gene expression
Although Scc2-like proteins are necessary to recruit the
Cohesin complex to chromosomes, patients with CdLS
usually do not show signiﬁcant cohesion defects (31,32),
suggesting that the diverse developmental deﬁcits are
caused by gene-expression changes similar to those in
Drosophila, where heterozygous Nipped-B mutations also
do not result in severe cohesion defects. In yeast, Cohesin
binds almost exclusively between genes and most binding
sites are between convergent transcription units. Coupled
with the ﬁnding that Scc2 does not colocalize with
Cohesin, this led to the idea that Cohesin loads onto chro-
mosomes at Scc2-binding sites and is subsequently pushed
to the end of the genes by RNA polymerase (33,34). This
contrasts sharply from the data obtained in Drosophila.
In Drosophila, Nipped-B was discovered in a genetic
screen for factors that facilitate long-range transcriptional
activation of the cut and Ultrabithorax (Ubx) homeobox
genes by enhancers positioned some 80 and 50kb
away from the promoters (9,35). It has been shown
previously that Nipped-B and Cohesin bind to the same
sites throughout the entire nonrepetitive Drosophila
genome. Here, Nipped-B seems to preferentially bind to
transcribed regions and overlap with RNA polymerase II.
According to these results, high transcriptional activity
does not seem to prevent Cohesin binding (36). The colo-
calization of Nipped-B with Cohesin supports the idea
that it dynamically regulates binding of Cohesin and sug-
gests additional mechanisms by which Cohesin might
aﬀect transcription (36). Although we have identiﬁed
NIPBL-mediated recruitment of histone deacetylases to
chromatin, which results in local alterations of the chro-
matin structure, the precise function of this interaction is
still unknown. The numerous genomic loci where Nipped-
B has been identiﬁed suggest a more general role in tran-
scriptional regulation. Whether NIPBL directly regulates
speciﬁc promoter activities or may participate in creating
a platform for the recruitment of speciﬁc transcription
(co-) factors needs to be analyzed in future experiments.
In this report, we show for the ﬁrst time a direct inter-
action and functional consequence of histone deacetylat-
ing enzymes with the Cohesin-loading protein NIPBL.
Although the precise function of this interplay is still
unknown, our data presented here give new insight into
the molecular pathology of CdLS and further contribute
to the hypothesis that it is likely not the result of defects in
cohesion; but rather, it is likely due to changes on chro-
matin structure and eﬀects on gene expression.
ACKNOWLEDGEMENTS
We are thankful to Matthew Deardorﬀ (Division of
Genetics, Department of Pediatrics, the University of
Pennsylavnia, USA) and Stefan Weger (Institut fu ¨ r
Infektionsmedizin, Charite ´ Campus Benjamin Franklin
in Berlin, Germany), for the critical and fruitful discussion
of the article.
FUNDING
Medical Faculty of Lu ¨ beck (E15-2008).
Conﬂict of interest statement. None declared.
REFERENCES
1. Uhlmann,F. (2004) The mechanism of sister chromatid cohesion.
Exp. Cell. Res., 296, 80–85.
2. Gruber,S., Haering,C.H. and Nasmyth,K. (2003) Chromosomal
Cohesin forms a ring. Cell, 112, 765–777.
3. Haering,C.H., Schoﬀnegger,D., Nishino,T., Helmhart,W.,
Nasmyth,K. and Lo ¨ we,J. (2004) Structure and stability of Cohesin’s
Smc1-kleisin interaction. Mol. Cell, 15, 951–964.
4. Vega,H., Waisﬁsz,Q., Gordillo,M., Sakai,N., Yanagihara,I.,
Yamada,M., van Gosliga,D., Kayserili,H., Xu,C., Ozono,K. et al.
(2005) Roberts syndrome is caused by mutations in ESCO2, a
human homolog of yeast ECO1 that is essential for the establish-
ment of sister chromatid cohesion. Nat. Genet., 37, 468–470.
5. Krantz,I.D., McCallum,J., DeScipio,C., Kaur,M., Gillis,L.A.,
Yaeger,D., Jukofsky,L., Wasserman,N., Bottani,A., Morris,C.A.
et al. (2004) Cornelia de Lange syndrome is caused by mutations
in NIPBL, the human homolog of Drosophila melanogaster
Nipped-B. Nat. Genet., 36, 631–635.
6. Tonkin,E.T., Wang,T.J., Lisgo,S., Bamshad,M.J. and Strachan,T.
(2004) NIPBL, encoding a homolog of fungal Scc2-type sister
chromatid cohesion proteins and ﬂy Nipped-B, is mutated in
Cornelia de Lange syndrome. Nat. Genet., 36, 636–641.
Nucleic Acids Research, 2008, Vol. 36, No. 20 64577. Musio,A., Selicorni,A., Focarelli,M.L., Gervasini,C., Milani,D.,
Russo,S., Vezzoni,P. and Larizza,L. (2006) X-linked Cornelia de
Lange syndrome owing to SMC1L1 mutations. Nat. Genet., 38,
528–530.
8. Deardorﬀ,M.A., Kaur,M., Yaeger,D., Rampuria,A., Korolev,S.,
Pie,J., Gil-Rodrı´guez,C., Arnedo,M., Loeys,B., Kline,A.D. et al.
(2007) Mutations in Cohesin complex members SMC3 and SMC1A
cause a mild variant of Cornelia de Lange syndrome with predo-
minant mental retardation. Am. J. Hum. Genet., 80, 485–494.
9. Rollins,R.A., Morcillo,P. and Dorsett,D. (1999) Nipped-B, a
Drosophila homologue of chromosomal adherins, participates in
activation by remote enhancers in the cut and Ultrabithorax genes.
Genetics, 152, 577–593.
10. Hakimi,M.A., Bochar,D.A., Schmiesing,J.A., Dong,Y., Barak,O.G.,
Speicher,D.W., Yokomori,K. and Shiekhattar,R. (2002) A chro-
matin remodelling complex that loads Cohesin onto human chro-
mosomes. Nature, 418, 994–948.
11. Baetz,K.K., Krogan,N.J., Emili,A., Greenblatt,J. and Hieter,P.
(2004) The ctf13-30/CTF13 genomic haploinsuﬃciency modiﬁer
screen identiﬁes the yeast chromatin remodelling complex RSC,
which is required for the establishment of sister chromatid cohesion.
Mol. Cell. Biol., 24, 1232–1244.
12. Huang,J., Hsu,J.M. and Laurent,B.C. (2004) The RSC nucleosome-
remodeling complex is required for Cohesin’s association with
chromosome arms. Mol. Cell., 13, 739–750.
13. Ogiwara,H., Enomoto,T. and Seki,M. (2007) The INO80 chromatin
remodeling complex functions in sister chromatid cohesion. Cell
Cycle, 6, 1090–1095.
14. Kaiser,F.J., Lu ¨ decke,H.J. and Weger,S. (2007) SUMOylation
modulates transcriptional repression by TRPS1. Biol. Chem., 388,
381–390.
15. Bo ¨ hm,J., Kaiser,F.J., Borozdin,W., Depping,R. and Kohlhase,J.
(2007) Synergistic cooperation of Sall4 and cyclin D1 in
transcriptional repression. Biochem. Biophys. Res. Commun., 356,
773–779.
16. Strachan,T. (2005) Cornelia de Lange syndrome and the link
between chromosomal function, DNA repair and developmental
gene regulation. Curr. Opin. Genet. Dev., 15, 258–264.
17. Selicorni,A., Russo,S., Gervasini,C., Castronovo,P., Milani,D.,
Cavalleri,F., Bentivegna,A., Masciadri,M., Domi,A., Divizia,M.T.
et al. (2007) Clinical score of 62 Italian patients with Cornelia de
Lange syndrome and correlations with the presence and type of
NIPBL mutation. Clin. Genet., 72, 98–108.
18. Seitan,V.C., Banks,P., Laval,S., Majid,N.A., Dorsett,D., Rana,A.,
Smith,J., Bateman,A., Krpic,S., Hostert,A. et al. (2006) Metazoan
Scc4 homologs link sister chromatid cohesion to cell and axon
migration guidance. PLoS Biol., 4.
19. Han,S., Lu,J., Zhang,Y., Cheng,C., Li,L., Han,L. and Huang,B.
(2007) HDAC inhibitors TSA and sodium butyrate enhanced the
human IL-5 expression by altering histone acetylation status at its
promoter region. Immunol. Lett., 108, 143–150.
20. Wei,L.N., Hu,X., Chandra,D., Seto,E. and Farooqui,M. (2000)
Receptor-interacting protein 140 directly recruits histone deacety-
lases for gene silencing. J. Biol. Chem., 275, 40782–40787.
21. Neuwald,A.F. and Hirano,T. (2000) HEAT repeats associated with
condensins, Cohesins, and other complexes involved in chromo-
some-related functions. Genome Res., 10, 1445–1452.
22. Riedel,C.G., Gregan,J., Gruber,S. and Nasmyth,K. (2004) Is chro-
matin remodeling required to build sister-chromatid cohesion?
Trends Biochem. Sci., 29, 389–392.
23. Nonaka,N., Kitajima,T., Yokobayashi,S., Xiao,G., Yamamoto,M.,
Grewal,S.I. and Watanabe,Y. (2002) Recruitment of Cohesin to
heterochromatic regions by Swi6/HP1 in ﬁssion yeast. Nat. Cell.
Biol., 4, 89–93.
24. Lechner,M.S., Schultz,D.C., Negorev,D., Maul,G.G. and
Rauscher,F.J. III. (2005) The mammalian heterochromatin protein
1 binds diverse nuclear proteins through a common motif that
targets the chromoshadow domain. Biochem. Biophys. Res.
Commun., 331, 929–937.
25. Gullerova,M. and Proudfoot,N.J. (2008) Cohesin complex promotes
transcriptional termination between convergent genes in S. pombe.
Cell, 132, 983–995.
26. Bernard,P., Maure,J.F., Partridge,J.F., Genier,S., Javerzat,J.P. and
Allshire,R.C. (2001) Requirement of heterochromatin for cohesion
at centromeres. Science, 294, 2539–2542.
27. Koch,B., Kueng,S., Ruckenbauer,C., Wendt,K.S. and Peters,J.M.
(2008) The Suv39h-HP1 histone methylation pathway is dispensable
for enrichment and protection of Cohesin at centromeres in mam-
malian cells. Chromosoma, 117, 199–210.
28. Cimini,D., Mattiuzzo,M., Torosantucci,L. and Degrassi,F. (2003)
Histone hyperacetylation in mitosis prevents sister chromatid
separation and produces chromosome segregation defects. Mol.
Biol. Cell, 14, 3821–3833.
29. Kimata,Y., Matsuyama,A., Nagao,K., Furuya,K., Obuse,C.,
Yoshida,M. and Yanagida,M. (2008) Diminishing HDACs by drugs
or mutations promotes normal or abnormal sister chromatid
separation by aﬀecting APC/C and adherin. J. Cell Sci., 121,
1107–1118.
30. Cairns,B.R., Lorch,Y., Li,Y., Zhang,M., Lacomis,L., Erdjument-
Bromage,H., Tempst,P., Du,J., Laurent,B. and Kornberg,R.D.
(1996) RSC, an essential, abundant chromatin-remodeling complex.
Cell, 87, 1249–1260.
31. Kaur,M., DeScipio,C., McCallum,J., Yaeger,D., Devoto,M.,
Jackson,L.G., Spinner,N.B. and Krantz,I.D. (2005) Precocious
sister chromatid separation (PSCS) in Cornelia de Lange syndrome.
Am. J. Med. Genet. A, 138, 27–31.
32. Vrouwe,M.G., Elghalbzouri-Maghrani,E., Meijers,M., Schouten,P.,
Godthelp,B.C., Bhuiyan,Z.A., Redeker,E.J., Mannens,M.M.,
Mullenders,L.H., Pastink,A. et al. (2007) Increased DNA
damage sensitivity of Cornelia de Lange syndrome cells: evidence
for impaired recombinational repair. Hum. Mol. Genet., 16,
1478–1487.
33. Glynn,E.F, Megee,P.C., Yu,H.G., Mistrot,C., Unal,E.,
Koshland,D.E., DeRisi,J.L. and Gerton,J.L. (2004) Genome-wide
mapping of the Cohesin complex in the yeast Saccharomyces cere-
visiae. PLoS Biol., E259, 1325–1339.
34. Lengronne,A., Katou,Y., Mori,S., Yokobayashi,S., Kelly,G.P.,
Itoh,T., Watanabe,Y., Shirahige,K. and Uhlmann,F. (2004) Cohesin
relocation from sites of chromosomal loading to places of conver-
gent transcription. Nature, 430, 573–578.
35. Rollins,R.A., Korom,M., Aulner,N., Martens,A. and Dorsett,D.
(2004) Drosophila nipped-B protein supports sister chromatid
cohesion and opposes the stromalin/Scc3 cohesion factor to facil-
itate long-range activation of the cut gene. Mol. Cell. Biol., 24,
3100–3111.
36. Misulovin,Z., Schwartz,Y.B., Li,X.Y., Kahn,T.G., Gause,M.,
MacArthur,S., Fay,J.C., Eisen,M.B., Pirrotta,V., Biggin,M.D. et al.
(2008) Association of Cohesin and Nipped-B with transcriptionally
active regions of the Drosophila melanogaster genome.
Chromosoma, 117, 89–102.
6458 Nucleic Acids Research, 2008, Vol. 36, No. 20